Canaccord analyst Richard Close said his view on Teladoc remains favorable heading into its Q4 results. The analyst expects in-line to slight upside results, but warns a potential downside could be 2019 guidance because he believes current consensus may be too high on adjusted EBITDA. Close reiterated his Buy rating and $94 price target on Teladoc shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.